Merck

Published Date:

Apr
25

Sun Pharma, Merck join hands to market diabetes drugs

By PTI

Sun Pharmaceutical Industries Ltd and MSD in India today said they have entered into a partnership to market diabetes drugs Sitagliptin and Sitaglipitin plus Metformin in the Indian market.
Apr
11

Sun Pharma, Merck form joint venture for generics

By Meghna Maiti

Sun Pharmaceutical Industries and US-based MSD (Merck) on Monday unveiled a joint venture for emerging markets, which will focus on developing innovative branded generic drugs for cardiovascular diseases, diabetes, hepatitis
Jan
06

Merck, Ranbaxy drug development deal called off

By PTI

US drug maker Merck & Co has terminated its nearly two-year-old alliance with Ranbaxy Laboratories to develop anti-infective medicines, which could have fetched the Indian firm USD 100 million over
May
11

Glenmark settles patent litigation with Merck

By PTI

Glenmark Pharmaceuticals today said it has settled a patent litigation with Merck & Co over its cholesterol lowering generic drug 'Ezetimibe', following which the firm can sell the medicine in
Oct
13

Sanmar Group sells bioscience arm to Merck

By G Balachandar

The $750 million Sanmar Group, a leading family-owned south Indian conglomerate engaged in chemical and engineering businesses, has sold Bangalore Genei, India, (BGIP), a bioscience company of the group, to
Mar
09

Big Pharma looks to vaccines to fill revenue gap

By REUTERS

Vaccines may be the next big thing for Big Pharma.